PubRank

A Phase III Study of Apixaban in Patients With Atrial Fibrillation (AVERROES)

Clinical Trial ID NCT00496769

PubWeight™ 20.71‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00496769

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Apixaban in patients with atrial fibrillation. N Engl J Med 2011 9.97
2 Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol 2012 1.76
3 The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov 2010 1.33
4 New oral anticoagulants may be particularly useful for asian stroke patients. J Stroke 2014 1.00
5 Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial. Stroke 2012 0.88
6 New antithrombotic agents--insights from clinical trials. Nat Rev Cardiol 2010 0.84
7 Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age Ageing 2015 0.84
8 Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands. PLoS One 2014 0.82
9 The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial. Eur Heart J 2013 0.80
10 Anticoagulant therapy in pediatrics. J Basic Clin Pharm 2014 0.80
11 Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions. J Am Heart Assoc 2016 0.77
12 Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study. Circ Arrhythm Electrophysiol 2013 0.76
13 Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review. Am J Cardiovasc Drugs 2016 0.75
14 Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev 2022 0.75
Next 100